Taylor Evangelisti,Rebecca Platoff,Polina Khrizman,Jamin C. Morrison,Upasana Joneja,Ashleigh A. Allen,Danica N. Giugliano,Michael Kwiatt,Steven J. McClane
Rectal small cell carcinoma is a rare and aggressive cancer subtype for which a consensus of optimal treatment has not yet been reached. This cancer presents a difficult surgical problem, and thus, the mainstay of treatment tends to mirror that of small cell carcinoma of the lung (chemotherapy, radiation therapy, and immune modulators). This brief report highlights current treatment options available for this rare and difficult entity. There is a significant need for large-center clinical trials and prospective studies to help determine the best treatment regimen to effectively care for patients with small cell carcinoma of the rectum.